The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

Treatment of hyperhidrosis can be divided into topical, oral, surgical, and nonsurgical treatments (botulinum toxin). These therapeutic options differ with respect to their efficacy, duration of ...

This development is part of Botanix’s strategy to expand payer coverage, now reaching over 110 million commercial lives, for its novel treatment targeting primary axillary hyperhidrosis, a condition ...

Specialists rely on the hyperhidrosis severity scale to assess the seriousness of the situation, as well as the discomfort in order to find an appropriate treatment. Treatments to consider The first ...

The Company believes DMT410 has the potential be to a first-in-class treatment for hyperhidrosis, acne, and facial aesthetics. As of September 30, 2024, the Company had $6.1 million in cash and cash ...

Cold sores, sore throats, migraines and conjunctivitis are among the conditions which will no longer be treated on the NHS by ...

Stock analysts at Roth Capital boosted their FY2024 EPS estimates for Journey Medical in a research note issued on Monday, November 4th. Roth Capital analyst J. Wittes now anticipates that the company ...

Botulinum toxin A injections are used as minimally invasive and promising treatment options for muscle spasms, cosmetic imperfections, and other conditions. This type is also used in treating ...

The partners say that the drug is a potential first-in-class therapy that could offer improved efficacy than drugs working against ... for acne and DMVT-504 for hyperhidrosis, which Roivant ...

Hyperhidrosis is defined as focal or generalized excessive sweating with a prevalence of 2.8% of the general population. This medical condition is associated with significant psychosocial ...

Adults with primary hyperhidrosis had an increased risk for anxiety and depression when compared with those without primary hyperhidrosis.